Drug and Medication Analysis & Statistics, November 2014 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

271-310 of about 4 200 reports

Purchase Reports From Reputable Market Research Publishers

World Generic Markets 24 NOVEMBER 2014

World Generic Markets 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Acquisition Of Allergan Will Transform Actavis Industry Brief - Teva Launches Celecoxib In Canada Industry Brief - Beximco Gains Canadian GMP Approval Industry Brief - FDA Rescinds ...

  • Industries : Drug and Medication
  • Countries : World, Canada, United States, United Kingdom, Switzerland, Europe, Saudi Arabia, North America
Cancer Drug News 24 NOVEMBER 2014

Cancer Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - BMS/Merck Battle For Melanoma Market Share Industry Brief - Revlimid Gains Swissmedic Approval For r/r MCL Industry Brief - Teva Launches Liquid Formulation Of Treanda Injection ...

  • Industries : Drug and Medication
  • Countries : United States
Anti-Infective Drug News 24 NOVEMBER 2014

Anti-Infective Drug News 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - AbbVie To Put Pressure On Gilead With Prospective HCV Approval Industry Brief - Pfizer's Trumenba Available In US Industry Brief - RedHill's RHB-105 Gains FDA QIDP Designation ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Switzerland
CNS Drug News 17 NOVEMBER 2014

CNS Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - FDA Approval Will See Lemtrada Become A Blockbuster Industry Brief - Impax Submits MAA For IPX066 Industry Brief - NeuroDerm Reports Positive Top-Line Phase II Results In Mod ...

  • Industries : Drug and Medication
  • Countries : Australia, Luxembourg, United States, Russian Federation, Germany, Belgium
Cancer Drug News 17 NOVEMBER 2014

Cancer Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology Industry Brief - First Patient Dosed In NeuVax+Herceptin Phase II Trial Industry Brief - Pooled Data Show ...

  • Industries : Drug and Medication
World Generic Markets 10 NOVEMBER 2014

World Generic Markets 10 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Canadian R&D Spending Will Require Renewed Focus Industry Trend Analysis - Sandoz Looks To Overturn Teva's Dominance Industry Brief - Canadian Generics Agreement To Create Savings ...

  • Industries : Drug and Medication
  • Countries : United States
Cancer Drug News 10 NOVEMBER 2014

Cancer Drug News 10 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Dendreon Unlikely To Find Buyer With Provenge's Underperformance Industry Brief - Altor Initiates Development Of ALT-803 In r/r MM Supported By Phase II SBIR Grant Industry Brief ...

  • Industries : Drug and Medication
  • Countries : Europe, Asia, World
Anti-Infective Drug News 10 NOVEMBER 2014

Anti-Infective Drug News 10 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Push For Ebola Vaccines Likely Not Fast Enough For Current Epidemic Industry Brief - Pfizer's Trumenba Approved In US For Prevention Of Meningococcal Meningitis B Industry Brief ...

  • Industries : Drug and Medication
  • Countries : United States
Cardiometabolic Drug News NOVEMBER 2014

Cardiometabolic Drug News NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF Industry Brief - Bayer Completes Acquisition Of Merck's Consumer Care Business; Collaboration Comes Into Effect Industry Brief ...

  • Industries : Drug and Medication
  • Countries : United States, Switzerland, Denmark
CNS Drug News 03 NOVEMBER 2014

CNS Drug News 03 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Preventive Migraine Treatment: A Significant Commercial Opportunity Industry Brief - Genervon Reports GM6 Phase IIa Trial Results In ALS/PD Industry Brief - Additional ADS-5102 ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Japan
Cancer Drug News 03 NOVEMBER 2014

Cancer Drug News 03 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • November 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Jakavi's Myelofibrosis Monopoly Set To End Industry Brief - DARA Appeals FDA To Amend Tamoxifen Citrate/Soltamox Label Industry Brief - Synta Initiates Phase II I-SPY 2 TRIAL ...

  • Industries : Drug and Medication
  • Countries : United States, Japan, China
Autoimmune Drug Focus OCTOBER 2014

Autoimmune Drug Focus OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Race For First US IPF Treatment Is A Dead Heat Industry Brief - Novo Nordisk Reports New Data From Tresiba Type I Diabetes Trial Industry Brief - EC Approves Lilly's Humalog 200 ...

  • Industries : Drug and Medication
  • Countries : United States
Cancer Drug News 27 OCTOBER 2014

Cancer Drug News 27 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Celgene Invests In Future With USD1bn Sutro Deal Industry Brief - Genmab Reaches USD10mn Milestone In Daratumumab Collaboration Industry Brief - ARIAD Updates On Final Recommendation ...

  • Industries : Drug and Medication
  • Countries : United States
World Generic Markets 20 OCTOBER 2014

World Generic Markets 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Leaked TPP Document Reveals Pharmaceutical Policy Disputes Remain Industry Brief - Impax To Acquire Tower Holdings And Subsidiaries Industry Trend Analysis - Congress Probes Generic ...

  • Industries : Drug and Medication
  • Countries : World, South Africa, United States, India, Kenya, Africa
Cancer Drug News 20 OCTOBER 2014

Cancer Drug News 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Fully Personalised Cancer Vaccines On The Rise Industry Trend Analysis - Pfizer's Palbociclib On Route For 2015 Launch Industry Brief - Galena Receives Japanese Patent Allowance ...

  • Industries : Drug and Medication
  • Countries : Australia, Canada, Japan
Anti-Infective Drug News 20 OCTOBER 2014

Anti-Infective Drug News 20 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Harvoni Approval Timed Perfectly With FDA Increase In Market Exclusivity Industry Brief - Savara Raises Funds To Advance AeroVanc; Completes Phase II Trial Enrolment Industry ...

  • Industries : Drug and Medication
  • Countries : Canada, United States, India
CNS Drug News 13 OCTOBER 2014

CNS Drug News 13 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Progressive MS Pipeline To See Increased Activity Industry Brief - Bayer Comments On NICE Guideline Regarding MS Management Industry Brief - Synthon Files Glatiramer ANDA With ...

  • Industries : Drug and Medication
  • Countries : France, United States, Europe
Cancer Drug News 13 OCTOBER 2014

Cancer Drug News 13 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Personalised Therapy Becoming A Mainstay In Cancer Treatment Industry Brief - FDA Approves Velcade For Previously Untreated Patients With MCL Industry Brief - BMS/Pharmacyclics/Janssen ...

  • Industries : Drug and Medication
Cardiometabolic Drug News OCTOBER 2014

Cardiometabolic Drug News OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Lilly's Trulicity Approval To Pave Way For Medium-Term GLP-1 Market Domination Industry Brief - Pfizer/Astellas Terminate Co-Promotion/Distribution Agreement In Japan Industry ...

  • Industries : Drug and Medication
World Generic Markets 06 OCTOBER 2014

World Generic Markets 06 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - GDUFA Science Priorities Underline Direction Of Generic Market Industry Brief - MPP Enters TAF Sublicensing Agreements Industry Brief - Sagent Acquires Omega Industry Brief - ...

  • Industries : Drug and Medication
Cancer Drug News 06 OCTOBER 2014

Cancer Drug News 06 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Oxford BioTherapeutics Instrumental In Several Of Big Pharma's ADC Developments Industry Brief - Halaven Launches In Australia For MBC Patients Industry Brief - ERYTECH Reports ...

  • Industries : Drug and Medication
Anti-Infective Drug News 06 OCTOBER 2014

Anti-Infective Drug News 06 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Gilead Acts To Secure Its Reign Over HIV-1 Market Industry Brief - Vibativ Now Available In Europe For HAP/VAP Industry Brief - FDA Grants Fast Track Designation For MEDI3902 ...

  • Industries : Drug and Medication
  • Countries : Japan, Canada
CNS Drug News 29 SEPTEMBER 2014

CNS Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Companion Diagnostics Could See New Alzheimer's Drugs Succeed Industry Brief - MedGenesis/Pfizer Enter Agreement For Potential PD Treatments Industry Trend Analysis - AstraZeneca/Lilly ...

  • Industries : Drug and Medication
Cancer Drug News 29 SEPTEMBER 2014

Cancer Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Amgen Vies For Swift Blinatumomab Approval Industry Brief - TG Agrees SPA With FDA For CLL Phase III Trial Industry Brief - Cephalon Acts To End Litigation Against Eagle Industry ...

  • Industries : Drug and Medication
  • Countries : China, Canada, United Kingdom
The Medicines Company Partnering 2009-2014

The Medicines Company Partnering 2009-2014

  • $ 995
  • Company report
  • November 2014
  • by Currentpartnering

The Partnering Agreements with The Medicines Company 2009-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report ...

  • Industries : Drug and Medication
Basic Pharmaceutical Product Manufacturing Market in the UK

Basic Pharmaceutical Product Manufacturing Market in the UK

  • $ 875
  • Industry report
  • October 2014
  • by Ibisworld

Picture of health: The market shows its dynamic nature in the face of dramatic change Basic Pharmaceutical Product Manufacturing in the UK The Basic Pharmaceutical Product Manufacturing market comprises ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
NRT Smoking Cessation Aids Market Analysis in Bulgaria

NRT Smoking Cessation Aids Market Analysis in Bulgaria

  • $ 898
  • Industry report
  • October 2014
  • by Euromonitor International

The products were neglected by potential consumers as the number of smokers in Bulgaria is amongst the highest in the EU, and many consider smoking as a freedom of choice that they do not wish to give ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Bulgaria

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Bulgaria

  • $ 898
  • Industry report
  • October 2014
  • by Euromonitor International

The increased variety of products, rapid relief benefits and improved distribution were also important factors for the growth in sales of cough, cold and allergy (hay fever) remedies over the review period. ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Analgesics Market Analysis in Bulgaria

Analgesics Market Analysis in Bulgaria

  • $ 898
  • Industry report
  • October 2014
  • by Euromonitor International

Analgin is the most popular systemic analgesic, mainly due to the long tradition of the Analgin brand in the country since its launch in 1954. It was the only systemic consumer health product on the industry ...

  • Industries : Drug and Medication
  • Countries : Bulgaria
Herbal/Traditional Products Market Analysis in Uzbekistan

Herbal/Traditional Products Market Analysis in Uzbekistan

  • $ 898
  • Industry report
  • October 2014
  • by Euromonitor International

Claims such as ‘contains natural and herbal ingredients’ are widely used to compete with other non-herbal products and have been very successful in attracting consumers and helped the area to record ...

  • Industries : Drug and Medication
  • Countries : Uzbekistan

62 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Pfizer Inc.

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.